ALLISON HULME - 11 Jan 2023 Form 3 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
11 Jan 2023
Net transactions value
$0
Form type
3
Filing time
12 Jan 2023, 16:01:06 UTC
Next filing
16 Jun 2023

No securities are beneficially owned.

Remarks:

No securities beneficially held. Exhibit 24: Power of Attorney